Icon

VYALEV (NDA216962)- (120MG/10ML;2400MG/10ML (12MG/ML;240MG/ML))

FOSCARBIDOPA; FOSLEVODOPA ABBVIE
120MG/10ML;2400MG/10ML (12MG/ML;240MG/ML)
No Yes
2035-Oct-21 Expired
None None
None No
VYALEV is a combination of foscarbidopa (an aromatic amino acid decarboxylation inhibitor) and foslevodopa (an aromatic amino acid) indicated for the treatment of motor fluctuations in adults with advanced Parkinson’s disease.
0 0 0
Total Other Developers None
Drugs with Suitability No
120MG/10ML;2400MG/10ML (12MG/ML;240MG/ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.